Home > Boards > US Listed > Cannabis > InMed Pharmaceuticals Inc. (INM)

Roth Capital Initiates Coverage on InMed with Buy

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
MJobserver Member Profile
Member Level 
Followed By 0
Posts 43
Boards Moderated 0
Alias Born 11/29/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2020 10:50:03 AM
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire (Canada) - 11/25/2020 7:30:00 AM
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire (US) - 11/25/2020 7:30:00 AM
InMed Announces Election of Directors PR Newswire (Canada) - 11/24/2020 8:00:00 PM
InMed Announces Election of Directors PR Newswire (US) - 11/24/2020 8:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/18/2020 12:32:11 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/18/2020 10:08:43 AM
InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics PR Newswire (US) - 11/18/2020 7:30:00 AM
InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics PR Newswire (Canada) - 11/18/2020 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 3:01:37 PM
InMed Pharmaceuticals Announces the Closing of US$8 Million Public Offering PR Newswire (US) - 11/16/2020 11:42:00 AM
InMed Pharmaceuticals Announces the Closing of US$8 Million Public Offering PR Newswire (Canada) - 11/16/2020 11:42:00 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 11/16/2020 6:24:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2020 1:20:41 PM
InMed Pharmaceuticals Reports First Quarter Fiscal 2021 IFRS Financial Results PR Newswire (Canada) - 11/13/2020 7:30:00 AM
InMed Pharmaceuticals Reports First Quarter Fiscal 2021 IFRS Financial Results PR Newswire (US) - 11/13/2020 7:30:00 AM
InMed Announces Pricing of US$8M Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM" PR Newswire (US) - 11/12/2020 9:10:00 AM
InMed Announces Pricing of US$8M Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM" PR Newswire (Canada) - 11/12/2020 9:10:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences